ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,018Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 783

$1M Total Retail Price of All Prescriptions

Rank: 49 out of 783

683 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 683 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 683 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 15,516 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 934 867 1 3
LEVOTHYROXINE SODIUM 843 707 2 1
FUROSEMIDE 651 587 3 7
LISINOPRIL 644 460 4 4
OMEPRAZOLE 584 402 5 6
AMLODIPINE BESYLATE 554 476 6 5
ATORVASTATIN CALCIUM 385 330 7 11
HYDROCODONE-ACETAMINOPHEN 371 293 S3 8 2
METOPROLOL TARTRATE 326 277 9 9
METFORMIN HCL 311 267 10 8
WARFARIN SODIUM 300 274 11 10
POTASSIUM CHLORIDE 294 226 12 16
CITALOPRAM HBR 281 249 13 19
ZOLPIDEM TARTRATE 255 210 14 23
PRAVASTATIN SODIUM 250 186 15 14
GABAPENTIN 247 201 16 15
SPIRONOLACTONE 226 212 17 57
NEXIUM 217 181 18 28
SERTRALINE HCL 189 143 19 22
METOPROLOL SUCCINATE 187 172 20 13
LOSARTAN-HYDROCHLOROTHIAZIDE 179 166 21 53
ESCITALOPRAM OXALATE 179 154 21 54
ATENOLOL 174 161 23 17
POLYETHYLENE GLYCOL 3350 171 130 24 43
ALENDRONATE SODIUM 170 167 25 25
TRAMADOL HCL 168 112 26 20
MIRTAZAPINE 165 137 27 52
FLUTICASONE PROPIONATE 163 113 28 46
LANTUS 162 140 29 38
KLOR-CON M20 155 141 30 48
TRAZODONE HCL 149 121 31 39
DONEPEZIL HCL 143 134 32 24
CLOPIDOGREL 131 116 33 29
PAROXETINE HCL 131 126 33 69
FLUOXETINE HCL 124 80 35 45
LOSARTAN POTASSIUM 122 119 36 18
NAMENDA 117 109 37 32
PLAVIX 116 101 38 51
RANITIDINE HCL 115 48 39 44
HYDROCHLOROTHIAZIDE 111 108 40 12
TRIAMTERENE-HCTZ 111 73 40 42
AZITHROMYCIN 108 79 42 41
CARVEDILOL 104 96 43 21
QUETIAPINE FUMARATE 100 90 44 79
SINGULAIR 99 64 45 90
ROPINIROLE HCL 99 74 45 74
NITROGLYCERIN PATCH 98 86 47 187
FENTANYL 97 96 S2 48 65
CRESTOR 97 76 48 27
TAMSULOSIN HCL 95 85 50 26
PANTOPRAZOLE SODIUM 88 66 51 30
LIPITOR 88 62 51 114
LANSOPRAZOLE 86 74 53 177
OXYBUTYNIN CHLORIDE 86 85 53 96
METOCLOPRAMIDE HCL 86 51 53 121
ADVAIR DISKUS 86 68 53 50
PROAIR HFA 85 49 57 56
ALLOPURINOL 81 81 58 31
MUPIROCIN 80 76 59 203
OLANZAPINE 79 69 60 108
CLONIDINE HCL 78 65 61 60
OXYBUTYNIN CHLORIDE ER 77 51 62 117
CIPROFLOXACIN HCL 76 68 63 62
CYCLOBENZAPRINE HCL 70 32 R 64 63
NOVOLOG 68 50 65 81
LIDODERM 67 66 66 132
NIFEDIPINE ER 67 62 66 135
SPIRIVA 66 59 68 59
SYNTHROID 63 60 69 47
LEXAPRO 62 51 70 181
NADOLOL 62 36 70 265
CYMBALTA 62 47 70 35
AMLODIPINE BESYLATE-BENAZEPRIL 61 61 73 83
PROPRANOLOL HCL 61 58 73 129
MELOXICAM 59 33 75 37
GLIPIZIDE 59 59 75 71
ENALAPRIL MALEATE 58 58 77 68
DETROL LA 58 50 77 220
ISOSORBIDE MONONITRATE ER 54 41 79 40
BENICAR HCT 53 39 80 201
PRAMIPEXOLE DIHYDROCHLORIDE 52 22 81 147
FLOVENT HFA 51 30 82 288
HYDROXYZINE HCL 50 18 R 83 165
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.